{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:36:15Z","timestamp":1792690575289,"version":"4.5.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRPSG-2024\\u201301\\u201302993"],"award-info":[{"award-number":["IIRPSG-2024\\u201301\\u201302993"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arr.2025.102990","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:33:24Z","timestamp":1765413204000},"page":"102990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Unveiling Alzheimer\u2019s disease (1901\u20132025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies"],"prefix":"10.1016","volume":"114","author":[{"given":"Premkumar Shantilal","family":"Baviskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6648-144X","authenticated-orcid":false,"given":"Hitendra Shaligram","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.102990_bib1","series-title":"RSC advances 14","first-page":"11057","article-title":"Review on anti-alzheimer drug development: approaches, challenges and perspectives","author":"Abdallah","year":"2024"},{"key":"10.1016\/j.arr.2025.102990_bib2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1471-4159.2009.06528.x","article-title":"BACE1 and BACE2 enzymatic activities in Alzheimer\u2019s disease","volume":"112","author":"Ahmed","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102990_bib3","first-page":"1986","article-title":"Quercetin nanoemulsion ameliorates neuronal dysfunction in experimental Alzheimer\u2019s disease model","volume":"11","author":"Alaqeel","year":"2022"},{"key":"10.1016\/j.arr.2025.102990_bib4","first-page":"426","article-title":"Discovery of azaindolin-2-one as a dual inhibitor of GSK3\u03b2 and tau aggregation with potential neuroprotective activity","volume":"15","author":"Ali","year":"2022"},{"key":"10.1016\/j.arr.2025.102990_bib5","first-page":"177","article-title":"About a peculiar disease of the cerebral cortex","volume":"30","author":"Alzheimer","year":"1907","journal-title":"Cent. F. \u00fcR. Nervenheilkd. Psychiatr."},{"key":"10.1016\/j.arr.2025.102990_bib6","unstructured":"Alzheimer\u2019s Association 2025 Alzheimer\u2019s Disease Facts and Figures."},{"key":"10.1016\/j.arr.2025.102990_bib7","first-page":"7058","article-title":"Prevalence, deaths and disability-adjusted life years due to Alzheimer\u2019s disease and other dementias in Middle East and North Africa, 1990\u20132021","volume":"15","author":"Amiri","year":"2025"},{"key":"10.1016\/j.arr.2025.102990_bib8","first-page":"281","article-title":"Oxidative stress, antioxidants and hypertension","volume":"12","author":"Amponsah-Offeh","year":"2023"},{"key":"10.1016\/j.arr.2025.102990_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1532-5415.1991.tb01647.x","article-title":"Dementia in Institutionalized Elderly: Relation to Sleep Apnea","volume":"39","author":"Ancoli-Israel","year":"1991","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2025.102990_bib10","article-title":"Transferrin-functionalized liposomes loaded with vitamin VB12 for Alzheimer\u2019s disease therapy","volume":"626","author":"Andrade","year":"2022"},{"key":"10.1016\/j.arr.2025.102990_bib11","article-title":"Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer\u2019s disease therapy","volume":"225","author":"Andrade","year":"2023"},{"key":"10.1016\/j.arr.2025.102990_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40708-023-00195-7","article-title":"A systematic review on machine learning and deep learning techniques in the effective diagnosis of Alzheimer\u2019s disease","volume":"10","author":"Arya","year":"2023","journal-title":"Brain Inform."},{"key":"10.1016\/j.arr.2025.102990_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10735-025-10406-6","article-title":"Efficacy of curcumin-selenium nanoemulsion in alleviating oxidative damage induced by aluminum chloride in a rat model of Alzheimer\u2019s disease","volume":"56","author":"Awad","year":"2025","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.arr.2025.102990_bib14","article-title":"Signs and symptoms preceding the diagnosis of Alzheimer\u2019s disease: a systematic scoping review of literature from 1937 to 2016","volume":"7","author":"Bature","year":"2017"},{"key":"10.1016\/j.arr.2025.102990_bib15","first-page":"8823","article-title":"Bace1 inhibitors for Alzheimer\u2019s disease: the past, present and any future?","author":"Bazzari","year":"2022","journal-title":"Mol. 27. MDPI"},{"key":"10.1016\/j.arr.2025.102990_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archneur.1994.00540180063015","article-title":"The natural history of Alzheimer\u2019s disease: description of study cohort and accuracy of diagnosis","author":"Becker","year":"1994","journal-title":"Arch. Neurol. 51. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2025.102990_bib17","series-title":"Self-reported sleep disturbance is associated with Alzheimer\u2019s disease risk in men. Alzheimer\u2019s & Dementia 11","first-page":"1090","author":"Benedict","year":"2015"},{"key":"10.1016\/j.arr.2025.102990_bib18","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s10072-025-08023-y","article-title":"Advances in biomarker discovery and diagnostics for alzheimer\u2019s disease","volume":"46","author":"Bhatia","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-510X(98)00128-2","article-title":"History of dementia and dementia in history: An overview","volume":"158","author":"Boller","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib20","first-page":"9","article-title":"Predictors of decline in Alzheimer\u2019s disease","volume":"27","author":"Boller","year":"1991"},{"key":"10.1016\/j.arr.2025.102990_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.neuro.31.060407.125529","article-title":"Active and Passive Immunotherapy for Neurodegenerative Disorders","volume":"31","author":"Brody","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.102990_bib22","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.8073293","article-title":"Rapid induction of Alzheimer A beta amyloid formation by zinc","volume":"265","author":"Bush","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102990_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/cercor\/7.1.86","article-title":"The autonomic-related cortex: pathology in Alzheimer\u2019s disease","volume":"7","author":"Chu","year":"1997","journal-title":"Cereb. cortex"},{"key":"10.1016\/j.arr.2025.102990_bib24","unstructured":"Ciccone, Isabella. 2022. ACI-35.030 and JACI-35.054 Vaccinations Demonstrate Safety in Early Alzheimer Disease. Neurology Live. Intellisphere, LLC: NA-NA."},{"key":"10.1016\/j.arr.2025.102990_bib25","unstructured":"Clinical Stages of Alzheimer\u2019s. 2025. Fisher Center for Alzheimer\u2019s Research Foundation. \u3008https:\/\/www.alzinfo.org\/understand-alzheimers\/clinical-stages-of-alzheimers\/\u3009. Accessed September 23."},{"key":"10.1016\/j.arr.2025.102990_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102990_bib27","first-page":"48","article-title":"Efficacy and safety of 2 fingolimod doses vs glatiramer acetate for the treatment of patients with relapsing-remitting multiple sclerosis: a randomized clinical trial","volume":"78","author":"Cree","year":"2021"},{"key":"10.1016\/j.arr.2025.102990_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2297450","article-title":"Antibodies to watch in 2024","volume":"16","author":"Crescioli","year":"2024","journal-title":"mAbs"},{"key":"10.1016\/j.arr.2025.102990_bib29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/106002809402800612","article-title":"Tacrine: First Drug Approved for Alzheimer\u2019s Disease","volume":"28","author":"Crismon","year":"1994","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.arr.2025.102990_bib30","article-title":"Alzheimer\u2019s disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2025.102990_bib31","article-title":"Alzheimer\u2019s disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2025.102990_bib32","first-page":"S64","article-title":"The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"6","author":"Cummings","year":"1998"},{"key":"10.1016\/j.arr.2025.102990_bib33","first-page":"20466","article-title":"Alzheimer\u2019s Disease Amyloid-\u03b2 Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits","volume":"276","author":"Curtain","year":"2001"},{"key":"10.1016\/j.arr.2025.102990_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.31887\/DCNS.2015.17.1\/bcuthbert","article-title":"Research Domain Criteria: toward future psychiatric nosologies","volume":"17","author":"Cuthbert","year":"2015","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.arr.2025.102990_bib35","first-page":"1403","article-title":"Selective loss of central cholinergic neurons in Alzheimer\u2019s disease","volume":"308","author":"Davies","year":"1976"},{"key":"10.1016\/j.arr.2025.102990_bib36","first-page":"1173","article-title":"Ideational apraxia","volume":"111","author":"De Renzi","year":"1988"},{"key":"10.1016\/j.arr.2025.102990_bib37","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s44318-024-00057-w","article-title":"New precision medicine avenues to the prevention of Alzheimer\u2019s disease from insights into the structure and function of \u03b3-secretases","volume":"43","author":"De Strooper","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2025.102990_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00314108","article-title":"Ideomotor apraxia in patients with dementia of alzheimer type","volume":"234","author":"Della Sala","year":"1987","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102990_bib39","unstructured":"Dementia. 2025. \u3008https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/dementia\u3009. Accessed September 23."},{"key":"10.1016\/j.arr.2025.102990_bib40","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","article-title":"Aducanumab: First Approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.arr.2025.102990_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/11533070-000000000-00000","article-title":"Intravenous immunoglobulins as a treatment for Alzheimer\u02bcs disease: rationale and current evidence","volume":"70","author":"Dodel","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.arr.2025.102990_bib42","first-page":"484","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021"},{"key":"10.1016\/j.arr.2025.102990_bib43","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2025.102990_bib44","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00018-022-04513-w","article-title":"Misfolded protein oligomers induce an increase of intracellular Ca2+ causing an escalation of reactive oxidative species","volume":"79","author":"Fani","year":"2022","journal-title":"Cell. Mol. life Sci. CMLS"},{"key":"10.1016\/j.arr.2025.102990_bib45","series-title":"The Lancet Neurology 20","first-page":"795","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","author":"Feigin","year":"2021"},{"key":"10.1016\/j.arr.2025.102990_bib46","first-page":"185","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease","volume":"547","author":"Fitzpatrick","year":"2017"},{"key":"10.1016\/j.arr.2025.102990_bib47","article-title":"Drug Administration FDA grants accelerated approval for Alzheimer\u2019s drug","author":"Food","year":"2021","journal-title":"FDA N. Release"},{"key":"10.1016\/j.arr.2025.102990_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A Phase II Trial of Tideglusib in Alzheimer\u2019s Disease","volume":"45","author":"for the ARGO investigators","year":"2015","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2025.102990_bib49","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s004060050101","article-title":"Clinical features of Alzheimer\u2019s disease","volume":"249","author":"F\u00f6rstl","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.arr.2025.102990_bib50","first-page":"1592","article-title":"Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer\u2019s Disease","volume":"11","author":"Galpern","year":"2024"},{"key":"10.1016\/j.arr.2025.102990_bib51","unstructured":"GBD Results. 2025. Institute for Health Metrics and Evaluation. \u3008https:\/\/vizhub.healthdata.org\/gbd-results\u3009. Accessed September 23."},{"key":"10.1016\/j.arr.2025.102990_bib52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1176\/appi.ajp.2014.13060821","article-title":"Baseline Neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study","volume":"171","author":"Geda","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.arr.2025.102990_bib53","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.48.5_Suppl_6.2S","article-title":"Differential diagnosis of Alzheimer\u2019s disease","volume":"48","author":"Geldmacher","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102990_bib54","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jnc.12203","article-title":"AZD 1080, a novel GSK 3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans","volume":"125","author":"Georgievska","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102990_bib55","article-title":"Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by \u03b2-amyloid1-42 in aged female mice","volume":"390","author":"Giacomeli","year":"2020"},{"key":"10.1016\/j.arr.2025.102990_bib56","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102990_bib57","first-page":"885","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984"},{"key":"10.1016\/j.arr.2025.102990_bib58","first-page":"704","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease","volume":"349","author":"Goate","year":"1991"},{"key":"10.1016\/j.arr.2025.102990_bib59","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","article-title":"Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau","volume":"85","author":"Goedert","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib60","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.arr.2025.102990_bib61","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10637-015-0278-7","article-title":"A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin","volume":"33","author":"Gray","year":"2015","journal-title":"Investig. N. Drugs"},{"key":"10.1016\/j.arr.2025.102990_bib62","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib63","unstructured":"Guerchet, Ma\u00eblenn, Martin Prince, and Matthew Prina. 2020. Numbers of people with dementia worldwide: An update to the estimates in the World Alzheimer Report 2015."},{"key":"10.1016\/j.arr.2025.102990_bib64","first-page":"101","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"H Ferreira-Vieira","year":"2016"},{"key":"10.1016\/j.arr.2025.102990_bib65","first-page":"101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007"},{"key":"10.1016\/j.arr.2025.102990_bib66","first-page":"1917","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018"},{"key":"10.1016\/j.arr.2025.102990_bib67","first-page":"7474","article-title":"Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying A\u03b21\u201343\/IL-10 cDNA","volume":"29","author":"Hara","year":"2011"},{"key":"10.1016\/j.arr.2025.102990_bib68","first-page":"383","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991"},{"key":"10.1016\/j.arr.2025.102990_bib69","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s Disease: The Amyloid Cascade Hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102990_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sageke.2002.37.cp14","article-title":"Aging: a theory based on free radical and radiation chemistry","volume":"2002","author":"Harman","year":"2002","journal-title":"Sci. Aging Knowl. Environ."},{"key":"10.1016\/j.arr.2025.102990_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401731","article-title":"Blood brain barrier-crossing delivery of felodipine nanodrug ameliorates anxiety-like behavior and cognitive impairment in Alzheimer\u2019s Disease","author":"He","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14336","article-title":"Identification of AS1842856 as a novel small-molecule GSK3\u03b1\/\u03b2 inhibitor against Tauopathy by accelerating GSK3\u03b1\/\u03b2 exocytosis","volume":"24","author":"He","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2025.102990_bib73","first-page":"S3","article-title":"Epidemiology of dementia and Alzheimer\u2019s disease","volume":"6","author":"Hendrie","year":"1998"},{"key":"10.1016\/j.arr.2025.102990_bib74","first-page":"824","article-title":"The Role and Pathogenesis of Tau Protein in Alzheimer\u2019s Disease","volume":"15","author":"Hong","year":"2025"},{"key":"10.1016\/j.arr.2025.102990_bib75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2025.102990_bib76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","article-title":"Lecanemab: first approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.arr.2025.102990_bib77","article-title":"Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer\u2019s disease","volume":"32","author":"Imam","year":"2024"},{"key":"10.1016\/j.arr.2025.102990_bib78","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer Disease and Related Tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2025.102990_bib79","first-page":"425","article-title":"Epidemiology of Alzheimer\u2019s disease and other dementias: Rising global burden and forecasted trends","volume":"10","author":"Javaid","year":"2021"},{"key":"10.1016\/j.arr.2025.102990_bib80","article-title":"Glycogen synthase kinase-3\u03b2 inhibition with 9-ING-41 attenuates the progression of pulmonary fibrosis","volume":"9","author":"Jeffers","year":"2019"},{"key":"10.1016\/j.arr.2025.102990_bib81","series-title":"In Proceedings of the 2nd International Conference on Control and Computer Vision","first-page":"87","article-title":"Early Diagnosis of Alzheimer\u2019s Disease Using Deep Learning","author":"Ji","year":"2019"},{"key":"10.1016\/j.arr.2025.102990_bib82","first-page":"587","article-title":"Sleep quality and preclinical Alzheimer disease","volume":"70","author":"Ju","year":"2013"},{"key":"10.1016\/j.arr.2025.102990_bib83","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s40265-024-02087-4","article-title":"Donanemab: first approval","volume":"84","author":"Kang","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.arr.2025.102990_bib84","first-page":"733","article-title":"The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987"},{"key":"10.1016\/j.arr.2025.102990_bib85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1976.00500040001001","article-title":"The Prevalence and malignancy of alzheimer disease: a major killer","volume":"33","author":"Katzman","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2025.102990_bib86","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/02652048.2020.1756971","article-title":"Memantine nanoemulsion: a new approach to treat Alzheimer\u2019s disease","volume":"37","author":"Kaur","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.arr.2025.102990_bib87","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s13346-020-00754-z","article-title":"Treatment of Alzheimer\u2019s diseases using donepezil nanoemulsion: an intranasal approach","volume":"10","author":"Kaur","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.arr.2025.102990_bib88","first-page":"1097","article-title":"Diagnosis of Alzheimer\u2019s disease","volume":"42","author":"Khachaturian","year":"1985"},{"key":"10.1016\/j.arr.2025.102990_bib89","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2147\/IJN.S239608","article-title":"Transferrin-modified osthole pegylated liposomes travel the blood-brain barrier and mitigate Alzheimer\u2019s Disease-Related Pathology in APP\/PS-1 Mice","volume":"15","author":"Kong","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2025.102990_bib90","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib91","unstructured":"Kraepelin, Emil. 1913. Psychiatrie; ein Lehrbuch f\u00fcr Studierende und \u00c4rzte. Vol. 3. Barth."},{"key":"10.1016\/j.arr.2025.102990_bib92","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102990_bib93","first-page":"1","article-title":"Design, development and in-vitro\/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer\u2019s disease","volume":"163","author":"Kulkarni","year":"2021"},{"key":"10.1016\/j.arr.2025.102990_bib94","first-page":"195","article-title":"A review on Alzheimer\u2019s disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015"},{"key":"10.1016\/j.arr.2025.102990_bib95","article-title":"Glutathione-and apolipoprotein E-grafted liposomes to regulate mitogen-activated protein kinases and rescue neurons in Alzheimer\u2019s disease","volume":"127","author":"Kuo","year":"2021"},{"key":"10.1016\/j.arr.2025.102990_bib96","first-page":"413","article-title":"Rescuing research participants after Alzheimer trials stop early: sending out an SOS","volume":"77","author":"Largent","year":"2020"},{"key":"10.1016\/j.arr.2025.102990_bib97","series-title":"2014 IEEE 11th international symposium on biomedical imaging (ISBI)","first-page":"1015","article-title":"Early diagnosis of Alzheimer\u2019s disease with deep learning","author":"Liu","year":"2014"},{"key":"10.1016\/j.arr.2025.102990_bib98","article-title":"The pathogenicity of PSEN2 variants is tied to A\u03b2 production and homology to PSEN1","author":"Liu","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2025.102990_bib99","article-title":"An inhibitor with GSK3\u03b2 and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer\u2019s disease","volume":"232","author":"Liu","year":"2023"},{"key":"10.1016\/j.arr.2025.102990_bib100","first-page":"440","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: New treatment paradigms","author":"Lanct\u00f4t","year":"2017"},{"key":"10.1016\/j.arr.2025.102990_bib101","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1176\/jnp.15.3.346","article-title":"Psychiatric symptoms vary with the severity of dementia in probable Alzheimer\u2019s disease","volume":"15","author":"Lopez","year":"2003","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.arr.2025.102990_bib102","series-title":"Handbook of clinical neurology","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0072-9752(07)01219-5","article-title":"Clinical symptoms in Alzheimer\u2019s disease","volume":"89","author":"L\u00f3pez","year":"2008"},{"key":"10.1016\/j.arr.2025.102990_bib103","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/089198879901200408","article-title":"Behavior rating scale for dementia: development of test scales and presentation of data for 555 individuals with Alzheimer\u2019s Disease","volume":"12","author":"Mack","year":"1999","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.arr.2025.102990_bib104","article-title":"Modelling the neuroanatomical progression of alzheimer\u2019s disease and posterior cortical atrophy","author":"Marinescu","year":"2020","journal-title":"arXiv"},{"key":"10.1016\/j.arr.2025.102990_bib105","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2025.102990_bib106","first-page":"1546","article-title":"Auguste D and Alzheimer\u2019s disease","volume":"349","author":"Maurer","year":"1997"},{"key":"10.1016\/j.arr.2025.102990_bib107","doi-asserted-by":"crossref","unstructured":"Mayeux, Richard, and Mary Sano. 1999. Treatment of Alzheimer\u2019s Disease. Edited by Alastair J.J. Wood. New England Journal of Medicine 341: 1670\u20131679. https:\/\/doi.org\/10.1056\/NEJM199911253412207.","DOI":"10.1056\/NEJM199911253412207"},{"key":"10.1016\/j.arr.2025.102990_bib108","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102990_bib109","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102990_bib110","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2025.102990_bib111","article-title":"Alzheimer\u2019s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023"},{"key":"10.1016\/j.arr.2025.102990_bib112","series-title":"Alzheimer\u2019s & Dementia 1","first-page":"55","article-title":"Ways toward an early diagnosis in Alzheimer\u2019s disease: the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","author":"Mueller","year":"2005"},{"key":"10.1016\/j.arr.2025.102990_bib113","first-page":"1437","article-title":"Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023"},{"key":"10.1016\/j.arr.2025.102990_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/alz.074725","article-title":"Use of plasma P-tau217 for enrichment in the Phase 2 PROSPECT-ALZ study of LY3372689 in early symptomatic Alzheimer\u2019s disease: Cohort selection and baseline characteristics","volume":"19","author":"Munsie","year":"2023","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2025.102990_bib115","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/01688638908400925","article-title":"Descriptive writing abilities in Alzheimer\u2019s disease","volume":"11","author":"Neils","year":"1989","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.arr.2025.102990_bib116","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP 520 for prevention trials in Alzheimer\u2019s disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.arr.2025.102990_bib117","unstructured":"Nivegacetor | ALZFORUM 2025. \u3008https:\/\/www.alzforum.org\/therapeutics\/nivegacetor\u3009. Accessed September 25."},{"key":"10.1016\/j.arr.2025.102990_bib118","series-title":"Biomedicine & Pharmacotherapy 153","article-title":"Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer\u2019s disease: In vitro, in vivo, and ex vivo evaluations","author":"Nojoki","year":"2022"},{"key":"10.1016\/j.arr.2025.102990_bib119","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer\u2019s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102990_bib120","first-page":"1959","article-title":"18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias","volume":"55","author":"O\u2019Brien","year":"2014"},{"key":"10.1016\/j.arr.2025.102990_bib121","article-title":"Nose-to-brain delivery of DHA-loaded nanoemulsions: A promising approach against Alzheimer\u2019s disease","volume":"670","author":"Otaegui","year":"2025"},{"key":"10.1016\/j.arr.2025.102990_bib122","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JGP.0b013e3181b0fa13","article-title":"Late-life depression, mild cognitive impairment, and dementia: possible continuum?","author":"Panza","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry 18. Elsevier"},{"key":"10.1016\/j.arr.2025.102990_bib123","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.2014.14040480","article-title":"Neuropsychiatric Symptoms as Predictors of Progression to Severe Alzheimer\u2019s Dementia and Death: The Cache County Dementia Progression Study","volume":"172","author":"Peters","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.arr.2025.102990_bib124","doi-asserted-by":"crossref","first-page":"658","DOI":"10.14336\/AD.2024.0286","article-title":"Amyloid-\u03b2 and phosphorylated tau are the key biomarkers and predictors of Alzheimer\u2019s disease","volume":"16","author":"Pradeepkiran","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.arr.2025.102990_bib125","first-page":"931","article-title":"Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer\u2019s disease","volume":"50","author":"Price","year":"1993"},{"key":"10.1016\/j.arr.2025.102990_bib126","unstructured":"Prince, Martin, Anders Wimo, Ma\u00eblenn Guerchet, Gemma-Claire Ali, Yu-Tzu Wu, and Matthew Prina. 2015. World Alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends. PhD Thesis, Alzheimer\u2019s Disease International."},{"key":"10.1016\/j.arr.2025.102990_bib127","doi-asserted-by":"crossref","DOI":"10.12775\/JEHS.2025.77.57093","article-title":"Advancing Alzheimer\u2019s Diagnosis: The Role of AI-A Review","volume":"77","author":"Rehan","year":"2025","journal-title":"J. Educ. Health Sport"},{"key":"10.1016\/j.arr.2025.102990_bib128","first-page":"1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A\u03b2 amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003"},{"key":"10.1016\/j.arr.2025.102990_bib129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40478-020-0884-2","article-title":"Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer\u2019s disease","volume":"8","author":"Roberts","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2025.102990_bib130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer\u2019s disease","volume":"50","author":"Rogers","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102990_bib131","first-page":"685","article-title":"The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease","volume":"21","author":"Rosenberg","year":"2013"},{"key":"10.1016\/j.arr.2025.102990_bib132","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/jcph.950","article-title":"BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid A\u03b2 Peptides","volume":"57","author":"Sakamoto","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2025.102990_bib133","first-page":"130","article-title":"Nanoencapsulated curcumin: enhanced efficacy in reversing memory loss in an Alzheimer disease model","volume":"14","author":"Savall","year":"2024"},{"key":"10.1016\/j.arr.2025.102990_bib134","first-page":"1577","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021"},{"key":"10.1016\/j.arr.2025.102990_bib135","first-page":"555","article-title":"The cholinergic system in aging and neuronal degeneration","volume":"221","author":"Schliebs","year":"2011"},{"key":"10.1016\/j.arr.2025.102990_bib136","first-page":"487","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991"},{"key":"10.1016\/j.arr.2025.102990_bib137","first-page":"652","article-title":"Recent advancements in the therapeutic approaches for Alzheimer\u2019s disease treatment: current and future perspective","volume":"16","author":"Sharma","year":"2025"},{"key":"10.1016\/j.arr.2025.102990_bib138","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2147\/IJN.S402447","article-title":"Nose to Brain Delivery of Astaxanthin\u2013Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer\u2019s Disease: Preparation, in vitro and in vivo Evaluation","volume":"18","author":"Shehata","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2025.102990_bib139","first-page":"221","article-title":"Development and evaluation of solid lipid nanoparticles for the clearance of A\u03b2 in Alzheimer\u2019s disease","volume":"15","author":"Shivananjegowda","year":"2023"},{"key":"10.1016\/j.arr.2025.102990_bib140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1532-5415.2007.01506.x","article-title":"Sleep-Disordered Breathing and Cognition in Older Women","volume":"56","author":"Spira","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2025.102990_bib141","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ana.410410510","article-title":"The absence of an apolipoprotein \u03f54 allele is associated with a more aggressive form of Alzheimer\u2019s disease","volume":"41","author":"Stern","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2025.102990_bib142","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1002\/alz.14237","article-title":"Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer\u2019s Prevention Initiative (API) Generation Studies","volume":"20","author":"Tariot","year":"2024","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2025.102990_bib143","first-page":"226","article-title":"Pathophysiology and management of Alzheimer\u2019s disease: An overview","volume":"9","author":"Thakur","year":"2018","journal-title":"J. Anal. Pharm. Res"},{"key":"10.1016\/j.arr.2025.102990_bib144","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1002\/alz.13026","article-title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer\u2019s disease","volume":"19","author":"Therriault","year":"2023","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2025.102990_bib145","first-page":"456","article-title":"Biomaterials for drug delivery and human applications","volume":"17","author":"Trucillo","year":"2024"},{"key":"10.1016\/j.arr.2025.102990_bib146","first-page":"267","article-title":"Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer\u2019s Disease Targeting","volume":"17","author":"Turkez","year":"2025"},{"key":"10.1016\/j.arr.2025.102990_bib147","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40199-018-0221-5","article-title":"Nicotinamide loaded functionalized solid lipid nanoparticles improves cognition in Alzheimer\u2019s disease animal model by reducing Tau hyperphosphorylation","volume":"26","author":"Vakilinezhad","year":"2018","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib148","first-page":"311","article-title":"Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer\u2019s disease: pitfalls and promise","volume":"83","author":"Van Dyck","year":"2018"},{"key":"10.1016\/j.arr.2025.102990_bib149","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2025.102990_bib150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2025.102990_bib151","first-page":"24","article-title":"The clinical diagnosis of Alzheimer\u2019s disease","volume":"44","author":"Wade","year":"1987"},{"key":"10.1016\/j.arr.2025.102990_bib152","first-page":"535","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002"},{"key":"10.1016\/j.arr.2025.102990_bib153","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1600749113","article-title":"Atomic-resolution structure of a disease-relevant A\u03b2(1\u201342) amyloid fibril","volume":"113","author":"W\u00e4lti","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib154","first-page":"262","article-title":"UB-311, a novel UBITh\u00ae amyloid \u03b2 peptide vaccine for mild Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2017"},{"key":"10.1016\/j.arr.2025.102990_bib155","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2025.102990_bib156","first-page":"199","article-title":"Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials","volume":"77","author":"Wessels","year":"2020"},{"key":"10.1016\/j.arr.2025.102990_bib157","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer\u2019s Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102990_bib158","first-page":"805","article-title":"Amyloid-\u03b2 immunisation for Alzheimer\u2019s disease","volume":"7","author":"Wisniewski","year":"2008"},{"key":"10.1016\/j.arr.2025.102990_bib159","first-page":"613","article-title":"Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women","volume":"306","author":"Yaffe","year":"2011"},{"key":"10.1016\/j.arr.2025.102990_bib160","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1002\/alz.14254","article-title":"Temporal trend and attributable risk factors of Alzheimer\u2019s disease and other dementias burden in China: Findings from the Global Burden of Disease Study 2021","volume":"20","author":"Yang","year":"2024","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2025.102990_bib161","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.arr.2025.102990_bib162","article-title":"Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"94","author":"Yu","year":"2023"},{"key":"10.1016\/j.arr.2025.102990_bib163","first-page":"2897","article-title":"Effects of aluminum on amyloid-beta aggregation in the context of Alzheimer\u2019s disease","volume":"12","author":"Zhang","year":"2019"},{"key":"10.1016\/j.arr.2025.102990_bib164","first-page":"1","article-title":"Oxidative Stress and the Pathogenesis of Alzheimer\u2019s Disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2025.102990_bib165","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","article-title":"Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer\u2019s Disease","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.arr.2025.102990_bib166","article-title":"A GBD 2021 study of Alzheimer\u2019s disease and other dementias attributable to metabolic risk factors and forecasts to 2045 in China","volume":"13","author":"Zhu","year":"2025"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725003368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725003368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:37:44Z","timestamp":1773920264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725003368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":166,"alternative-id":["S1568163725003368"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102990","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling Alzheimer\u2019s disease (1901\u20132025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102990"}}